TW466115B - Pharmaceutical composition of antioxidant from equilenin - Google Patents

Pharmaceutical composition of antioxidant from equilenin Download PDF

Info

Publication number
TW466115B
TW466115B TW086117838A TW86117838A TW466115B TW 466115 B TW466115 B TW 466115B TW 086117838 A TW086117838 A TW 086117838A TW 86117838 A TW86117838 A TW 86117838A TW 466115 B TW466115 B TW 466115B
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
salt
scope
patent application
item
Prior art date
Application number
TW086117838A
Other languages
English (en)
Chinese (zh)
Inventor
Steven Jay Adelman
Dorothy Helen Prozialeck
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of TW466115B publication Critical patent/TW466115B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW086117838A 1996-12-10 1997-11-27 Pharmaceutical composition of antioxidant from equilenin TW466115B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76257996A 1996-12-10 1996-12-10

Publications (1)

Publication Number Publication Date
TW466115B true TW466115B (en) 2001-12-01

Family

ID=25065472

Family Applications (1)

Application Number Title Priority Date Filing Date
TW086117838A TW466115B (en) 1996-12-10 1997-11-27 Pharmaceutical composition of antioxidant from equilenin

Country Status (14)

Country Link
EP (1) EP0944391A1 (fr)
JP (1) JP2001506628A (fr)
KR (1) KR20000069412A (fr)
CN (1) CN1239892A (fr)
AR (1) AR010344A1 (fr)
AU (1) AU743586B2 (fr)
BR (1) BR9714384A (fr)
CA (1) CA2272087A1 (fr)
HU (1) HUP0000569A3 (fr)
IL (1) IL130071A0 (fr)
NZ (1) NZ336343A (fr)
TW (1) TW466115B (fr)
WO (1) WO1998025626A1 (fr)
ZA (1) ZA9711052B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10445011B2 (en) 2017-05-19 2019-10-15 Winbond Electronics Corp. Flash memory storage apparatus

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271221B1 (en) * 1996-12-10 2001-08-07 American Home Products Corporation Use of equilenin as an antioxidant
DE19915576A1 (de) * 1999-03-30 2000-10-05 Jenapharm Gmbh Equileninderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US20030139458A1 (en) * 2001-12-10 2003-07-24 Yansheng Du Treatment of neurodegenerative and cardiovascular disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US4937238A (en) * 1986-03-04 1990-06-26 The Board Of Regents Of The University Of Nebraska Prevention of mammary carcinoma
EP0240717A3 (fr) * 1986-03-04 1990-05-16 Board of Regents of the University of Nebraska Prévention du carcinome du sein
US5545635A (en) * 1995-05-23 1996-08-13 Eli Lilly And Company Inhibiting bone loss with equilenin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10445011B2 (en) 2017-05-19 2019-10-15 Winbond Electronics Corp. Flash memory storage apparatus

Also Published As

Publication number Publication date
WO1998025626A1 (fr) 1998-06-18
AU5370798A (en) 1998-07-03
EP0944391A1 (fr) 1999-09-29
NZ336343A (en) 2000-11-24
JP2001506628A (ja) 2001-05-22
KR20000069412A (ko) 2000-11-25
CN1239892A (zh) 1999-12-29
CA2272087A1 (fr) 1998-06-18
AU743586B2 (en) 2002-01-31
IL130071A0 (en) 2000-02-29
HUP0000569A3 (en) 2000-11-28
ZA9711052B (en) 1999-06-09
AR010344A1 (es) 2000-06-07
BR9714384A (pt) 2000-05-16
HUP0000569A2 (hu) 2000-10-28

Similar Documents

Publication Publication Date Title
US8586770B2 (en) Unsaturated steroid compounds
AU675307B2 (en) Nasal pharmaceutical composition containing a progestational agent
TW200306801A (en) Farnesoid X-activated receptor agonists
Mishra et al. Updates in bile acid-bioactive molecule conjugates and their applications
JP2007254476A (ja) 抗酸化活性を有するエストラジオールの非エストロゲン誘導体
JP2002500616A (ja) 神経学的に活性なアミノステロイド
JP2005508368A (ja) 高コレステロール濃度に関連した疾患の治療方法
TW466115B (en) Pharmaceutical composition of antioxidant from equilenin
DE68911509T2 (de) 26-aminocholesterol und derivate und analoge davon bei der regulierung der cholesterolanhäufung in den körpergefässen.
AU739146B2 (en) Pregnan-3-ol-20-ones
AU703814B2 (en) Antioxidant
CN114945556A (zh) 用于核酸转染的类脂质及其用途
TW422693B (en) 17<beta>-dihydroequilenin as an antioxidant
WO2018151937A1 (fr) Composés induisant des vacuoles, leurs procédés de préparation et d'utilisation
TW464653B (en) B-ring estratriene diols
AU743519B2 (en) 17alpha-dihydroequilenin for use as a medical antioxidant
US6271221B1 (en) Use of equilenin as an antioxidant
JP2001518896A (ja) エストロゲン活性を有するエストラ−５（１０），７−ジエン
CN108464970B (zh) 一种代谢及外排双抑制型的安五脂素纳米乳及其制备方法
TW513305B (en) Ginkgolide composition which inhibits glucocorticoid release
KR20200086541A (ko) 방사선 치료 증폭을 위한 사이토스테롤-독소루비신 유도체 및 이를 유효성분으로 포함하는 암 질환 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees